8 completed. 8 Phase 1, 6 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 8 |
| Phase 2 | 6 | Completed 6 |
Follow Blindness: new trials by email Literature Review of Blindness trials Research Report on Blindness
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of NPI-001 Tablets for RP Associated With Usher Syndrome NPI-001, Placebo - Usher Syndromes | Phase 1 / Phase 2 | Completed | Nacuity Pharmaceuticals, Inc. | 49 | 2020-09-03 | 2026-07-01 |
| Study to Evaluate Safety and Tolerability of QR-421a in Subjects With RP Due to Mutations in Exon 13 of the USH2A Gene QR-421a, Sham-procedure (dose cohort 1&2 only) - Retinitis Pigmentosa, Usher Syndrome Type 2 | Phase 1 / Phase 2 | Completed | ProQR Therapeutics | 20 | 2019-03-06 | 2022-04-20 |
| ADVM-022 Intravitreal Gene Therapy for Wet AMD ADVM-022 - Wet Age-related Macular Degeneration, Neovascular Age-related Macular Degeneration | Phase 1 | Completed | Adverum Biotechnologies, Inc. | 30 | 2018-11-14 | 2023-08-08 |
| A Clinical Trial of Dantrolene Sodium in Pediatric and Adult Patients With Wolfram Syndrome dantrolene sodium - Wolfram Syndrome, Diabetes Mellitus | Phase 1 / Phase 2 | Completed | Washington University School of Medicine | 21 | 2017-01-01 | 2024-03-13 |
| Combined tDCS and Vision Restoration Training in Post-acute Stroke: an Exploratory Efficacy and Safety Study verum tDCS, sham tDCS, VRT - Hemianopia, Stroke | Phase 1 / Phase 2 | Completed | University of Magdeburg | 19 | 2013-03-01 | 2016-03-09 |
| Combined tDCS and Vision Restoration Training in Subacute Stroke Rehabilitation: A Pilot Study tDCS, Standard rehabilitation - Hemianopia, Stroke | Phase 1 / Phase 2 | Completed | University of Magdeburg | 14 | 2013-01-01 | 2016-10-17 |
| Computer Vision System for the Blind Veteran initial system, modified system - Blindness | Phase 1 | Completed | VA Office of Research and Development | 16 | 2011-11-01 | 2016-01-22 |
| Clinical Trial Evaluating Rituximab in Ocular Cicatricial Pemphigoid Rituximab - Ocular Cicatricial Pemphigoid | Phase 1 / Phase 2 | Completed | University of Alabama at Birmingham | 3 | 2006-01-01 | 2026-05-04 |
Eye Diseases (2) · Hemianopsia (2) · Retinal Diseases (2) · Stroke (2) · Usher Syndromes (2) · Ataxia (1) · Diabetes Mellitus (1) · Eye Abnormalities (1) · Eye Diseases, Hereditary (1) · Macular Degeneration (1) · Optic Atrophy (1) · Pemphigoid, Benign Mucous Membrane (1) · Pemphigoid, Bullous (1) · Retinal Degeneration (1)
Nervous System Diseases (8) · Neurologic Manifestations (8) · Pathological Conditions, Signs and Symptoms (8) · Sensation Disorders (8) · Signs and Symptoms (8) · Vision Disorders (7) · Eye Diseases (6) · Abnormalities, Multiple (3) · Congenital Abnormalities (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (3) · Deaf-Blind Disorders (3) · Deafness (3) · Ear Diseases (3) · Eye Diseases, Hereditary (3)
Dantrolene (1) · Intravitreal Injections (1) · Rituximab (1) · Transcranial Direct Current Stimulation (1)
University of Magdeburg (2) · Adverum Biotechnologies, Inc. (1) · Nacuity Pharmaceuticals, Inc. (1) · ProQR Therapeutics (1) · University of Alabama at Birmingham (1) · VA Office of Research and Development (1) · Washington University School of Medicine (1)
United States (5) · Austria (2) · Germany (2) · Australia (1) · Canada (1) · France (1)
Bernhard A Sabel, Prof. Dr. (1) · Cha-Min Tang, PhD MD (1) · Craig A Elmets (1) · Fumihiko Urano, MD (1) · Lee Anderson, MD (1) · Raimund Alber, MS (1)
PMID 28082176, PMID 31215818, PMID 34185708, PMID 37418643, PMID 38152412
2018 (1), R21DK113487 (1)